- 127
- 31 236
Voices In Validation
เข้าร่วมเมื่อ 30 ก.ย. 2019
Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at ivtnetwork.com.
Laboratory Review Process and Its Impact on Compliance
The pharmaceutical quality control laboratory serves one of the most important functions in pharmaceutical production and control. Poor laboratory practice may yield compliance issues, higher costs, increased cycle time, and delayed product introductions. Avoiding all that means consistent lab review processes and good document controls. Here to review effective laboratory review processes, and their importance to regulatory compliance is David Strauss of SciCord.
About Our Guest:
David Strauss, CEO and Founder, SciCord
David co-founded SciCord LLC in 2014. SciCord implemented the first production ELN solution in 2015 and has continued to grow both in functionality and customer base. SciCord’s solution has evolved to encompass integrated ELN & LIMS functionality with plug-and-play modules preconfigured to automate many laboratory functions.
Prior to 2014, David created an ELN application for GSK which virtually eliminated paper from the worldwide pre-clinical organization and was credited with a 30% productivity increase. David grew the application over 15 years to service more than 6000 scientists who in turn created over 800,000 experiments. As ELN champion, David was involved and often led the design, development, testing, validation, implementation, and regulatory compliance defense.
David started his career with Merck, working in the lab and then specializing in information and laboratory automation.
Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at ivtnetwork.com.
#VoicesInValidation
#IVTNetwork
#SciCord
About Our Guest:
David Strauss, CEO and Founder, SciCord
David co-founded SciCord LLC in 2014. SciCord implemented the first production ELN solution in 2015 and has continued to grow both in functionality and customer base. SciCord’s solution has evolved to encompass integrated ELN & LIMS functionality with plug-and-play modules preconfigured to automate many laboratory functions.
Prior to 2014, David created an ELN application for GSK which virtually eliminated paper from the worldwide pre-clinical organization and was credited with a 30% productivity increase. David grew the application over 15 years to service more than 6000 scientists who in turn created over 800,000 experiments. As ELN champion, David was involved and often led the design, development, testing, validation, implementation, and regulatory compliance defense.
David started his career with Merck, working in the lab and then specializing in information and laboratory automation.
Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at ivtnetwork.com.
#VoicesInValidation
#IVTNetwork
#SciCord
มุมมอง: 167
วีดีโอ
EU GMP Annex 1 Revision 2022 Implementation
มุมมอง 2.6K2 ปีที่แล้ว
The much-discussed revision to the EU GMP Annex 1 is expected to be published early this year, bringing some major changes to drug developers’ current process and manufacturing methods for sterile products. Although the draft revision has been widely shared and commented on, it is still unclear the total impact this document may have across regulated industries. Here to share their perspective ...
Critical Thinking, Assessing Risk, and Patient Safety - Setting the Record Straight on CSA
มุมมอง 1472 ปีที่แล้ว
We have entered an era of accelerated digitalization in Life Sciences. Innovation has been thrust upon many across industries as a need to work remotely, automating tasks and virtual collaborations were necessary during the pandemic. Maintaining this accelerated pace, fully embracing the adoption of technology and automation, is the next hurdle we face. Will CSA get us there? Here to demystify ...
Risk Revolution: Risk Tolerance & Risk Acceptance
มุมมอง 1892 ปีที่แล้ว
Welcome to Risk Revolution, a monthly series of Voices in Validation, brought to you by the IVT Network. The goal of this series is to advance the maturity of risk management practices within the industry, by covering topics that challenge quality professionals to seek opportunities to improve and advance the ways in which they perceive and manage risk. This week, series coordinator Nuala is jo...
Sustainability without Compromise, the story of BioFoam
มุมมอง 212 ปีที่แล้ว
As we begin to harness the data delivered through AI, and further refine the processes around automation, supply chain, new norms around surface contamination and sanitization, IVT Network strives to bring to light some of the most innovative products and uses for the benefit of the entire life sciences industry. In drug and device production we are accustomed to concern about contaminants, and...
Measuring Cough As Clinical Evidence
มุมมอง 452 ปีที่แล้ว
Trending Technologies in Life Sciences - A Special episode series of Voices in Validation This week, Stacey is joined by Dr. Peter Small, from Hyfe about an AI cough monitor that detects and records every cough and turns that into reliable clinical data. We are working at accelerated speeds to digitalize and automate across pharmaceutical and medical devices. There are unique challenges inheren...
The New Norm for Life Sciences Talent Evolution
มุมมอง 262 ปีที่แล้ว
This week, Stacey is joined by Justin Bechtel, of Bechtel Recruiting Group. This seems to be the era of the great resignation. Now more than ever in recent history employees have the advantage, and this is true across regulated industries as well. Unfortunately, the amount of training and experience necessary in maintaining GMP standards, delivering quality products, and patient-first service, ...
Risk Revolution: ICH Q9 Revision, Is it enough?
มุมมอง 2182 ปีที่แล้ว
Welcome to Risk Revolution, a monthly series of the Voices in Validation podcast, brought to you by the IVT Network. The goal of this series is to advance the maturity of risk management practices within the industry, by covering topics that challenge quality professionals to seek opportunities to improve and advance the ways in which they perceive and manage risk. In this episode, Stacey is jo...
The Quality Control Response to COVID Disruption in Labs
มุมมอง 262 ปีที่แล้ว
This week, Stacey is joined by Brian Nunally, Global Head of Quality Control, Seqirus. Stacey and Brian discuss updates and insights on laboratory operations since the pandemic began. COVID has changed nearly every facet of society, and many of the changes will be permanent, not returning to the “old ways.” While we often take comfort in the status quo, this pandemic has allowed us many positiv...
Data Integrity and Integrating Automation
มุมมอง 1872 ปีที่แล้ว
This week, Karen Ginsbury shares her ideas on data integrity lapses, and how automating now can save your business in the future. Karen looks at how the pharmaceutical industry and even society misunderstand what integration truly is. Karen shares her thoughts on how the industry can advance forward despite self-inflicted obstacles. About Our Guest: Karen Ginsbury is a pharmaceutical consultant...
Digital Transformation - Has the Pharma Industry’s ‘Digital Moment’ Arrived?
มุมมอง 1362 ปีที่แล้ว
This week, Stacey is joined by Chinmoy Roy to answer some important questions about the current state of digital transformation across the pharmaceutical industry. Digital transformation in the pharmaceutical industry is crucial for better patient care, cost-effectiveness, greater transparency, improved production, and drug development. Across the pharmaceutical industry, companies are at varyi...
Impact of COVID-19 on GXP Inspection Practices
มุมมอง 422 ปีที่แล้ว
This week, Kelly Simpliciano hosts a discussion on GXP inspection principles and the changes in processes and expectations stemming from the Covid-19 pandemic. More work than ever is being completed by virtual connections, remote activities, and through systems and processes more reliant on collaborative team efforts and digital technologies. Understanding how these elements affect our inspecti...
Get Smart With Your Data
มุมมอง 342 ปีที่แล้ว
This week, Ferdi Steinmann shares his three things you can do to bring intelligence into everything you do. Ferdi breaks down the barriers to intelligence and helps show the path to overcoming the tsunami of data in life sciences. Ferdi covers medical innovations, patient applications, wearables, and the internet of medical things. About Our Guest: Ferdi has nearly 25 years of driving strategy ...
Integrate Risk into Change Control
มุมมอง 1142 ปีที่แล้ว
This week, Alan Golden hosts a comprehensive discussion on the changes driven by risk and conversely risk updates that are driven by change as well as risk integration. This episode is brought to you by IVT Network's Validation Week. Alan Golden: Alan Golden is Principal at Design Quality Consultants, LLC where he works with clients training and advising on topics in the medical device industry...
Risk Revolution: Foundations in Quality Risk Management w/Dr. Tim Sandle
มุมมอง 1862 ปีที่แล้ว
In this episode, Stacey is joined by series coordinator Nuala Calnan and regular contributor Valerie Mulholland to discuss the book "Foundations in Quality Risk Management" with the author, Dr. Tim Sandle. One of the key topics of discussion is dealing with "Fuzzy Logic", and how to manage situations that appear vague, and how that applies to the Pharmaceutical and Healthcare industries. Welcom...
Cognitive Biases in Strategy and Execution
มุมมอง 472 ปีที่แล้ว
Cognitive Biases in Strategy and Execution
Ruggedness of Visible Residue Limits for Cleaning Validation
มุมมอง 1922 ปีที่แล้ว
Ruggedness of Visible Residue Limits for Cleaning Validation
Risk Revolution: Foundations in Quality Risk Management
มุมมอง 732 ปีที่แล้ว
Risk Revolution: Foundations in Quality Risk Management
The Essentials for Regulatory Compliance and Customer Satisfaction
มุมมอง 303 ปีที่แล้ว
The Essentials for Regulatory Compliance and Customer Satisfaction
Opportunities & Challenges in Transitioning to Risk-Based Monitoring in Clinical Trials
มุมมอง 673 ปีที่แล้ว
Opportunities & Challenges in Transitioning to Risk-Based Monitoring in Clinical Trials
Unintended Consequences Of USP Compliance
มุมมอง 273 ปีที่แล้ว
Unintended Consequences Of USP Compliance
Good Distribution Practices and Audit Readiness
มุมมอง 5383 ปีที่แล้ว
Good Distribution Practices and Audit Readiness
A Risk-Based Critical Thinking Approach to Computer Systems Validation
มุมมอง 3693 ปีที่แล้ว
A Risk-Based Critical Thinking Approach to Computer Systems Validation
Revolutionizing Drug Production: A Shift to Continuous Manufacturing
มุมมอง 823 ปีที่แล้ว
Revolutionizing Drug Production: A Shift to Continuous Manufacturing
Risk Revolution: Disrupting the Paradigm
มุมมอง 283 ปีที่แล้ว
Risk Revolution: Disrupting the Paradigm
CSA Revolution Reaction with David Nettleton
มุมมอง 1243 ปีที่แล้ว
CSA Revolution Reaction with David Nettleton
Thank you Mr. Golden, this is very helpful
👌👌
We appreciate your efforts from India
Excellent discussion. We love watching your quality discussion from India
Excellent discussion. Thanks very much
Thnx
How are combination products classified in Europe as in EU MDR ?
Single entity combo products must be chemically combined, like “silicone ring combined with progesterone”. Where the silicone ring is used as a delivery vehicle to deliver the drug product. Not sure if a pen injector is a single entity combination product?
A very interesting insight. It's fantastic to view the universal transition away from Computer System Validation toward Computer System Assurance. Also excellent to see how important it is to have a partner.
Thank you Stacy
Very nice presentation ... Speaker is very passionate to the topic Thnx "Voices in Validation"
Very nice thnx
How are you going to justify not validating "big data algorithms", regardless of what data (primary og supportive) they are analyzing, if the direct output of those algorithms are used for making decision affecting product quality or patient safety? The need for validation depends on intended use. Some kind of validation of those algorithms has to be done surely. "Self-validating" is not a concept in itself nor exact science, but relies on the person/system behind producing the algorithm. Arguing that Tesla is not performing process validation is not an valid argument.
Contact Doctor Akhigbe for your MS cure with his herbal medication
Message him on Whats App now
✝️ 2348140126449🇳🇬🇳🇬⏭️⏭️❤️❤️❤️
How should the storage conditions limits be established? For example temperature from 0 to 45°C.
Can the panelists comment on the following pl? 1. There are lots of tools that are coming in today for testing, devops etc., to what extent do we need to extend the Qualification to these tools? 2. Are there clear pointers coming as to where its reqd n where its not? Where do we stop?
Thank you so much ... one note please about the filter example: is it allowed to write on piece of paper outside the official record?
Loved this episode!!
Unfortunately the discussions were hardly on Test automation which the topic was supposed to be
Can u pl.send the cybersecurity SOp that you were talking about...to. gsvk68@gmail.com
Thanks a lot for the channel a d topics pl. Can you pl let know when are you planning to hold the webinar on the standards that were being spoken about. Is it possible to list them down in the description to start with or point us to any link that has it?
She cut his talk
It's was very knowledgeable conversation. Thank you really got insight about CSA.
Excellent information
First time visit. THANK YOU SO MUCH for Drs. Bernard Hsu and Paul Pluta on YOUR show! Added your and their links to my SUBS! In a more humorous vein I was reminded about a "NEW" laxative in competition with ExLax is... "FeatherLax" ... which seems to "tickle-the sh*t" out of you! BUT, warning, if you overdose you may die laughing!
Sorry to say very less informative.
Thank you so much from India
Ajaz Hussain 👌
PAT thinking is now ... and for the remote, digital future.
I am a CSV(quality analyst) professional. I should say that was an excellent discussion on CSA and it helped me a better idea on the topic. But I have few questions and it would really be helpful if some expertise could answer it. 1. If there will be less focus on documentation of test records, what exactly would a QA do? Will QA become a risk based "tester" ? Then how different will a tester be different from a Quality Analyst? How is the risk identified? 2. Will CSA require less quality analysts than CSV as there will be very less documentation? In other words how does CSA impact on jobs?
I also have same concern about it regarding manpower management. Does we required new skilled person on same or existing QA will work on?
This is a wonderful session😃👍
Deep thinking and great sharing about CSV and CSA, Thank You
thanks for the important information . could you please do some more videos on CSV
that will really help.
a tip: you can watch movies on flixzone. Me and my gf have been using them for watching a lot of movies these days.
@Atlas Gideon definitely, been watching on flixzone} for since november myself :D
Good Info
Thank you for this insightful forward-thinking approach to computer system validation that integrates both technology and methodology